Industrial buyers specifying battery-grade lithium carbonate (Li2CO3 ≥99.5%) in July 2026 rely heavily on Chinese converters, with CBCIE Metals publishing daily ex-works contract prices for that grade [S2].
Technical- and pharma-grade lithium carbonate remains a separate, lower-volume track: CAS 554-13-2, molecular formula Li2CO3, molecular weight 73.89, supplied as a solid at 98.00% purity by research-grade vendors such as APExBIO at 1 mL / 100 g / 500 g pack sizes [S1].
Battery-grade vs technical-grade: two parallel markets
Battery-grade lithium carbonate is defined by a minimum 99.5% Li2CO3 assay and tracked as a separate exchange-quoted contract on CBCIE Metals, alongside lithium hydroxide and lithium metal under the Lithium Industry Chain taxonomy [S2].
Technical-grade 99% Li2CO3 is the workhorse spec quoted by Indian export-platform suppliers such as Desar on ExportersIndia, typically packed in bottles with CAS 554-13-2 listed and purity described as 99% [S5]. That same CAS number — 554-13-2 — anchors every grade, so procurement should always confirm the Li2CO3 assay and impurity panel rather than relying on the CAS alone [S1][S5].
Chemistry, solubility, and handling anchors
Lithium carbonate is the dilithium salt of carbonic acid: Li2CO3, MW 73.89, solid at room temperature, essentially insoluble in ethanol, with reported aqueous solubility ≥3.95 mg/mL in H2O and ≥2.74 mg/mL in DMSO with ultrasonic assistance [S1]. Storage is at ambient temperature and the material ships on blue ice from research-vendor warehouses, reflecting a stable inorganic salt rather than a refrigerated hazardous chemical [S1].
For process engineers sizing flow meter lines on Li2CO3 slurry dosing, the aqueous solubility ceiling around 3.95 mg/mL at room temperature [S1] defines the practical upper concentration before re-precipitation, which matters for any closed-loop crystallization skid. The 7Li isotopically-enriched variant (Lithium-7Li carbonate) is a separate product line tracked by ChemicalBook suppliers for NMR and fusion-reactor applications [S7].
Selection criteria: assay, impurity panel, and form
The four decision criteria that separate qualified from disqualified Li2CO3 lots in 2026 are: (1) Li2CO3 assay — 99.5% for battery-grade vs 99% technical vs 98% research; (2) impurity panel — Na, Ca, Mg, Fe, Cu, sulfate, chloride limits apply to battery-grade; (3) physical form — powder, granular, or 10 mM aqueous solution, with research vendors offering all three [S1]; (4) regulatory framing — battery-grade converters ship under REACH/SDS for cathode feedstock, while pharma-grade lots clear FDA drug-master-file routes.
Pharma-grade Li2CO3 is dominated by ANDA filers: the FDA drug database lists Pfizer's reference listed drug Lithium Carbonate tablet 300 mg (NDA 016834, approved prior to 1 January 1982, currently discontinued) [S4], and Glenmark Pharmaceuticals' ANDA 091544 covering the same 300 mg oral tablet as a generic [S6]. That same lithium-carbonate API is the input into bipolar-disorder therapies and is the reason the material carries a dual specification: industrial reagent on one side, pharma API on the other [S1][S4][S6].
Who supplies what: a tiered map
Tier-1 — Chinese battery-grade converters and trading desks: these publish daily battery-grade Li2CO3 contract prices on CBCIE Metals, with 99.5% Li2CO3 the contract spec and the Lithium Industry Chain tracking lithium ore, precursor, cathode material, lithium salt, electrolyte, cell, and waste-lithium-battery categories end-to-end [S2]. Tier-2 — Indian and global technical-grade exporters: ExportersIndia lists Desar and other Indian suppliers quoting 99% purity, bottle-pack, country-of-origin India, CAS 554-13-2 [S5]. Tier-3 — research and pharma-grade specialists: APExBIO sells 98% purity Li2CO3 in 1 mL / 100 g / 500 g SKUs [S1]; isotopically-enriched 7Li2CO3 is a separate supply chain via ChemicalBook-listed manufacturers [S7].
For North American procurement teams tracking servo motor duty cycles on bag-handling and palletizing lines that move Li2CO3 drums, the practical sourcing decision is whether the application demands 99.5% battery-grade under an exchange-quoted contract [S2] or whether 99% technical-grade in bottle or drum pack from an Indian or Chinese exporter is sufficient [S5]. Pharma and clinical researchers requiring an FDA-registered API source are pointed to ANDA 091544 (Glenmark) and NDA 016834 (Pfizer reference listed drug) records in the FDA drug database [S4][S6].
Pricing and contract mechanics on the battery-grade line
CBCIE Metals publishes a per-day ex-works contract trading price for Battery Grade Lithium Carbonate (Li2CO3: 99.5%), and that price is the primary reference number for cathode makers and traders booking July 2026 tonnage [S2]. The platform organizes the lithium value chain into 17 sub-categories — lithium ore, precursor, cathode material, lithium salt, anode material, diaphragm, cell, electrolyte, cobalt material, nickel material, manganese material, module, waste lithium battery, sodium battery, chemical additives, solvent & electrolyte, lithium battery products — and the Li2CO3 spot quote is the chain's central pricing signal [S2].
For comparison, the research-vendor 100 g pack of 98% lithium carbonate from APExBIO carries a list price of ¥454.00, with a 500 g pack at ¥1,545.00 and a 1 mL 10 mM aqueous solution at the same ¥454.00 entry point [S1]. These are small-pack reference prices, not industrial tonnage, but they confirm the chemistry, purity, and CAS behind every Li2CO3 SKU on the market [S1]. Specifiers wiring pressure sensor loops into Li2CO3 storage tanks should match the wetted-material certificate to that same 98-99.5% assay window rather than assuming one grade across the supply base [S1][S2].
Standards, regulatory anchors, and failure modes
Industrial Li2CO3 grades are governed by purchaser specifications rather than a single ISO grade, while battery-grade converters align to cathode-maker impurity windows that typically reference GB/T, Chinese industry-standards for Li2CO3, and customer-specific QA protocols. Pharma-grade Li2CO3 clears FDA drug-master-file routes: the Glenmark ANDA 091544 generic 300 mg oral tablet demonstrates the regulatory pathway, and the Pfizer NDA 016834 reference listed drug is the original benchmark [S4][S6].
Common failure modes in 2026 sourcing are: (a) mistaking 99% technical-grade Li2CO3 for battery-grade 99.5% and discovering elevated Na/Ca/Mg in cathode pilot runs; (b) specifying Li2CO3 at 98% purity where the application actually needs 99% or 99.5% — APExBIO's 98% catalog SKU is research-only and labelled "not for diagnostic or therapeutic use" [S1]; (c) ignoring the 7Li isotope requirement in NMR or fusion applications, where standard Li2CO3 is unsuitable and Lithium-7Li2 carbonate must be substituted [S7].
Trackable signals for the next sourcing cycle
Two verifiable signals to watch through Q3 2026: the daily CBCIE Metals Battery Grade Li2CO3 (99.5%) contract trading price, which is the canonical Chinese ex-works reference for cathode-grade tonnage [S2]; and any new ANDA filings or revisions in the FDA Lithium Carbonate drug database, since Pfizer's NDA 016834 is currently marked discontinued and Glenmark's ANDA 091544 defines the active generic supply for the U.S. market [S4][S6]. The 7Li-enriched Li2CO3 supply line on ChemicalBook remains a niche but trackable indicator for NMR-grade and fusion-research demand [S7].
For related coverage, see UHP Graphite Electrode Pricing 2026: EAF Steel Demand, Diameter Specs, and Sourcing.